ArticleWorld journal of urology2025

Cost-effectiveness of nivolumab compared with surveillance for adjuvant treatment of muscle-invasive urothelial carcinoma at high risk of recurrence in France.

Sylvie Negrier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.